Programpunkter

Equal access to health data is far from reality today and there is a lack of comparison between countries. To motivate, understand and increase progress, we start from the position that highlighting current status, sharing evidence related to practices and policies, and identifying major enablers and obstacles across national and regional boundaries is necessary. Therefore, we have invited panel participants to introduce five different countries, representing five different stages of and approaches to patients’ ORA implementation.

CANCELLED. 
Research on real-world data is becoming increasingly important. The current restriction to clinical data in Germany limits the view of the patient. To gain comprehensive insights, claims data can be added to the existing knowledge. However, standardized transfer of German claims data into OMOP CDM is currently not possible. In this paper, we conducted an evaluation regarding the coverage of source vocabularies and data elements of German claims data in OMOP CDM. We point out the need to extend vocabularies and mappings to support research on German claims data.

Reproducibility imposes some special requirements at different stages of each project, including reproducible workflows for the analysis including to follow best practices regarding code style and to make the creation of the manuscript reproducible as well. Available tools therefore include version control systems such as Git and document creation tools such as Quarto or R Markdown. However, a re-usable project template mapping the entire process from performing the data analysis to finally writing the manuscript in a reproducible manner is yet lacking. This work aims to fill this gap by presenting an open source template for conducting reproducible research projects utilizing a containerized framework for both developing and conducting the analysis and summarizing the results in a manuscript. This template can be used instantly without any customization.

Privacy-enhancing technologies (PET) are becoming more important in the context of open data and data sharing approaches. Anonymization as one PET can address privacy concerns by manipulating data in a way that it can't be related to a person anymore. Resulting constrains in data quality need to be thoroughly investigated to ensure that implications drawn from the data are not biased. In our real-world application, we aimed to provide utility-preserved anonymized data while scaling privacy.  

Implementation Status of the Proposal for a Regulation of the European Health Data Space in Portugal.

Each epidemic and pandemic is accompanied by an infodemic. The infodemic during the COVID-19 pandemic was unprecedented. Accessing accurate information was difficult and misinformation harmed the pandemic response, the health of individuals, and trust in science, governments and societies. WHO built a community-centered information platform, the HIVE, to deliver on the vision of ensuring that all people everywhere have access to the right information, at the right time, in the right format in order to make decisions to protect their health.

Lets talk about interoperable order set creation than can be used by any EMR